Monica Kelly was thrilled to learn she was expecting her second child.
Bristol Myers’ subcutaneous version of Opdivo gets earlier PDUFA date
The FDA has shortened the timeline for coming to a decision on Bristol Myers Squibb’s subcutaneous version of its blockbuster PD-1 inhibitor Opdivo. The company